apt12264-sup-0001-Table S1-3.docxWord document16K

Table S1. Statistical power.

Table S2. Treatment effects of TU-100 on quality of life. There were no significant overall differences in quality of life or any of the quality of life indices between groups.

Table S3. Adverse events affecting at least 2 participants in any group. TU-100 was safe and well tolerated throughout the study. Overall, there were no significant differences between groups for any of the observed adverse events.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.